N/A
N=460
An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia
Cognitive Impairment
Bottom Line
View on ClinicalTrials.gov: NCT01504672 ↗Enrolled (actual)
460
Serious AEs
0.0%
Results posted
Nov 2021
Primary outcome: Primary: Number of Patients Readmitted Because of Drug Related Reasons — 40; 50 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Medication review (Other)
- Age
- Older Adult · 65+ yrs
- Sex
- All
- Sponsor
- Umeå University
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients Readmitted Because of Drug Related Reasons |
40; 50 | — |
| SECONDARY Cost for Visits for Readmissions and to the Emergency Department Compared Between Patients in the Control Group and Intervention Group. |
2340; 2630 | — |
| SECONDARY Number of Participants Institutionalized After Discharge, in Control Group and Intervention Group. |
17; 24 | — |
| SECONDARY Frequency of Emergency Department Visits During the 6-month Follow-up. |
190; 184 | — |
| SECONDARY Change in the Number of Participants With Potentially Inappropriate Medications, According to the Swedish National Board of Health and Welfare, at Admission and Discharge Between Intervention and Control Group |
13; 5 | — |
Summary
The aim of this randomized controlled study is to investigate if medication reviews performed by a clinical pharmacist as part of a ward team can reduce drug related problems and reduce readmissions to hospital among elderly patients (≥65 years) with dementia and cognitive failure.
Four hundred and sixty patients will be recruited and randomized to control (usual care) and intervention group (enhanced service in which a pharmacist is part of the health care team).
Six months after the last patient of the 460 has been discharged the study will be closed. Data about the number of readmissions and visits to the emergency room will be collected during the six-month follow-up and also, the costs associated with each visit or admission. Time until institutionalization will be compared between intervention group and control group.
Eligibility Criteria
Inclusion Criteria
- Patients with dementia or cognitive impairment
- Patients ≥ 65 years
Exclusion Criteria
- Patients previously admitted to the study wards during the study period
Data sourced from ClinicalTrials.gov (NCT01504672). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.